Filing Details
Pelthos Therapeutics Inc. (NYSE:PTHS) filed a Form 8-K with the Securities and Exchange Commission on October 30, 2026, disclosing a material event.
8k filedNYSE:PTHS
Pelthos Therapeutics Inc. (PTHS) Reports Material Event to SEC
Pelthos Therapeutics Inc. (NYSE:PTHS) filed a Form 8-K with the Securities and Exchange Commission on October 30, 2026, disclosing a material event.
At publication ·
What changed
Pelthos Therapeutics Inc. (NYSE:PTHS) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Pelthos Therapeutics Inc. filed a Form 8-K with the SEC on October 30, 2026, disclosing a material event requiring shareholder disclosure.
- The company's stock trades at $9.40 with a market capitalization of $15.5 million.
- Material events reported on Form 8-K include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Pelthos Therapeutics Inc.'s stock currently trades at $9.40 with a market capitalization of $15.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Pelthos Therapeutics Inc.'s stock.
All SEC filings for Pelthos Therapeutics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PTHS Stock Page
Frequently Asked Questions
Where can I read PTHS's SEC filings?
Browse all filings on our PTHS SEC filings page.
What types of SEC filings does Pelthos Therapeutics Inc. file?
Public companies like Pelthos Therapeutics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.